Article
The clinical and physiological spectrum of interferon-alpha induced thyroiditis: toward a new classification.
Hepatology (Baltimore, Md.) - 1 Apr 2006
Mandac Jamie C, Chaudhry Sonal, Sherman Kenneth E, Tomer Yaron
Abstract excerpt
Interferon-alpha (IFNalpha) is a major treatment modality for several malignant and nonmalignant diseases, especially hepatitis C. Prospective studies have shown that up to 15% of patients with hepatitis C receiving IFNalpha develop clinical thyroid disease, and up to 40% were reported to develop thyroid antibodies. Some of these complications may result in discontinuation of interferon therapy. Thus, interferon...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.